Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Enveric Biosciences, Inc. ENVB
$1.44
-$0.15 (-10.56%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
4056783.00000000
-
week52high
18.50
-
week52low
1.30
-
Revenue
0
-
P/E TTM
0
-
Beta
0.47884100
-
EPS
-12.98000000
-
Last Dividend
18490.50000000
-
Next Earnings Date
11 мая 2023 г. в 20:00
Описание компании
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Alliance Global Partners | Buy | 01 июн 2022 г. | |
| Aegis Capital | Hold | Buy | 08 мар 2022 г. |
| Aegis Capital | Buy | 08 июл 2021 г. | |
| Maxim Group | Buy | 28 июн 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Tucker Joseph Edward | A | 74196 | 44000 | 25 янв 2023 г. |
| Kanubaddi Avani | A | 48346 | 10000 | 25 янв 2023 г. |
| Hagel Jillian Marie | A | 35802 | 12000 | 25 янв 2023 г. |
| Facchini Peter J. | A | 40865 | 17000 | 25 янв 2023 г. |
| Ward Carter Julian | A | 744429 | 744429 | 19 янв 2022 г. |
| Kanubaddi Avani | A | 1127787 | 1127787 | 19 янв 2022 г. |
| Hagel Jillian Marie | A | 23802 | 10500 | 13 окт 2021 г. |
| Hagel Jillian Marie | A | 13302 | 1021 | 13 окт 2021 г. |
| Facchini Peter J. | A | 23856 | 10500 | 13 окт 2021 г. |
| Facchini Peter J. | A | 13356 | 1021 | 13 окт 2021 г. |
Новостная лента
The 7 Most Promising Psychedelic Stocks to Buy in February
InvestorPlace
05 февр 2023 г. в 14:30
Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several pharmaceutical companies are now investigating their potential therapeutic value.
Enveric Biosciences to Present at the BIO CEO & Investor Conference
Business Wire
01 февр 2023 г. в 07:33
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced that CEO Joseph Tucker, Ph.D., will present at the BIO CEO & Investor Conference being held February 6-9, 2023, at the Marriott Marquis in New York City.
Enveric Biosciences to Present at the 6th Annual Neuroscience Innovation Forum and Biotech Showcase during "J.P. Morgan Health Care Week 2023"
Business Wire
21 дек 2022 г. в 07:30
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, announced today that the company will present at the 6th Annual Neuroscience Forum and the Biotech Showcase™. Both events will be held live and are scheduled to coincide with the 41st Annual J.P. Morgan Health Care Conference in San Francisco, January 9-12, 2023.
Enveric Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
Business Wire
31 авг 2022 г. в 07:30
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Avani Kanubaddi, President & COO of Enveric, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022. Mr. Kanubaddi will present on Wedn
7 Psychedelics Stocks to Buy for a Big Drug Boom
InvestorPlace
30 авг 2022 г. в 15:02
Psychedelics stocks are becoming increasingly mainstream, in part due to changing social attitudes. Psychedelic drugs “are a loosely grouped class of drugs that are able to induce altered thoughts and sensory perceptions.